The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
American Journal of Preventive Cardiology · 2023-09 · 15 · 100527
DOI: 10.1016/j.ajpc.2023.100527 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Preventive Cardiology, 2023-09. Verfasst von Arielle Abovich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Defense, National Heart, Lung, and Blood Institute.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of established HF risk factors, such as hypertension, diabetes, and obesity. Many individuals have multiple risk factors, placing them at even higher risk. In addition, these risk factors disproportionately impact various racial and ethnic groups. Recognizing the rising health and economic burden of HF in the U.S., the 2022 American Heart Association / American College of Cardiology / Heart Failure Society of America (AHA/ACC/HFSA) Heart Failure Guideline placed a strong emphasis on prevention of HF. The purpose of this review is to highlight the role of both primary and secondary prevention in HF, as outlined by the recent guideline, and address the role of the preventive cardiology community in reducing the prevalence of HF in at-risk individuals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
- Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, United States.
Förderung
- U.S. Department of Defense
- National Heart, Lung, and Blood Institute
Zitieren
APA
Abovich, A., Matasic, D. S., Cardoso, R., Ndumele, C. E., Blumenthal, R. S., Blankstein, R., & Gulati, M. (2023). The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention. American Journal of Preventive Cardiology, 15, 100527. https://doi.org/10.1016/j.ajpc.2023.100527
Vancouver
Abovich A, Matasic DS, Cardoso R, Ndumele CE, Blumenthal RS, Blankstein R, et al. The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention. American Journal of Preventive Cardiology. 2023;15:100527. doi:10.1016/j.ajpc.2023.100527
BibTeX
@article{Abovich2023,
author = {Abovich, Arielle and Matasic, Daniel S and Cardoso, Rhanderson and Ndumele, Chiadi E and Blumenthal, Roger S and Blankstein, Ron and Gulati, Martha},
title = {The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention},
journal = {American Journal of Preventive Cardiology},
year = {2023},
volume = {15},
pages = {100527},
doi = {10.1016/j.ajpc.2023.100527}
}
EUVIMED